Brief: Aytu Biopharma Inc - On January 4, 2023, Board Approved A 1-For-20 Reverse Stock Split Of Company's Common Stock, Effective January 6, 2023

Aytu Biopharma

05/01/2023 21:52

Jan 5 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA INC - ON JANUARY 4, 2023, BOARD  APPROVED A
1-FOR-20 REVERSE STOCK SPLIT OF COMPANY'S COMMON STOCK,
EFFECTIVE JANUARY 6, 2023
    * AYTU BIOPHARMA INC - CO'S SHARES WILL BEGIN TRADING ON A
SPLIT-ADJUSTED BASIS ON NASDAQ CAPITAL MARKET COMMENCING UPON
MARKET OPEN ON JANUARY 6, 2023
    * AYTU BIOPHARMA INC - IMMEDIATELY AFTER REVERSE STOCK SPLIT
BECOMES EFFECTIVE, THERE WILL BE ABOUT 3.4 MILLION SHARES OF
COMMON STOCK ISSUED AND OUTSTANDING

Further company coverage:  AYTU.O 
 ((Reuters.Briefs@thomsonreuters.com;;))